Gaura Kishor Rath

Gaura Kishor Rath

Auto-generated profile, based on publicly available information

Gaura Kishor Rath

All India Institute of Medical Sciences (AIIMS)

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 September 2026 in The BRICS Health Journal
Verified
Journal Article
Open access
PDF file
Ashok SharmaAshok Sharma
Ashok Sharma
ABAlisha Behera
Alisha Behera
SQSahar Qazi
Sahar Qazi
SGSamanvaya Gupta
Samanvaya Gupta
EDEkta Dhamija
Ekta Dhamija
GRGaura Kishor Rath
Gaura Kishor Rath
Cancer remains a major public health challenge across BRICS member countries. Together, these countries represent more than 40% of the global population and account for approximately 9.0 million new cancer cases and 4.66 million cancer deaths. This review aims to summarize cancer epidemiology across the 11 BRICS member countries, with emphasis on breast and ovarian cancers, describe India’s cancer-control and digital-health architecture, and assess the evidence and translational potential of iOncology.ai. Cancer patterns and access to screening, early diagnosis, and specialist oncology care vary across member countries. Breast cancer is among the leading malignancies affecting women and is the leading female cancer in most BRICS countries. Ovarian cancer is less common but is frequently diagnosed at advanced stages and is associated with poor outcomes. In India, cancer-control activities are delivered through the National Health Mission, the National Programme for Prevention and Control of Non-Communicable Diseases, and complementary surveillance, population-based screening, tertiary-care, and financial-protection mechanisms. The Viksit Bharat 2047 vision and Digital India programme provide a policy context for digital health development, including the Ayushman Bharat Digital Mission. Within this ecosystem, iOncology.ai is an national artificial-intelligence platform undergoing pilot-stage clinical validation and implementation evaluation. The review also identifies priorities for collaborative digital oncology in the context of India’s BRICS Chairship in 2026.